Kura Oncology, Inc. (KURA)
Kura Oncology has a market cap or net worth of $823.32 million. The enterprise value is $399.15 million.
The next earnings date is Tuesday, May 2, 2023, after market close.
|Estimated Earnings Date||May 2, 2023|
Kura Oncology has 68.44 million shares outstanding. The number of shares has increased by 0.96% in one year.
|Shares Change (YoY)||+0.96%|
|Shares Change (QoQ)||+1.35%|
|Owned by Insiders (%)||2.75%|
|Owned by Institutions (%)||106.46%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 18.56, with a Debt / Equity ratio of 0.03.
|Debt / Equity||0.03|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -30.80% and return on invested capital (ROIC) is -33.80%.
|Return on Equity (ROE)||-30.80%|
|Return on Assets (ROA)||-29.00%|
|Return on Capital (ROIC)||-33.80%|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$1.07M|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -27.12% in the last 52 weeks. The beta is 0.93, so Kura Oncology's price volatility has been similar to the market average.
|52-Week Price Change||-27.12%|
|50-Day Moving Average||12.52|
|200-Day Moving Average||14.31|
|Average Volume (30 Days)||656,198|
Short Selling Information
The latest short interest is 7.10 million, so 10.37% of the outstanding shares have been sold short.
|Short Previous Month||7.09M|
|Short % of Shares Out||10.37%|
|Short % of Float||14.08%|
|Short Ratio (days to cover)||10.70|
|Earnings Per Share (EPS)||-$2.03|
The company has $438.20 million in cash and $14.02 million in debt, giving a net cash position of $424.17 million or $6.20 per share.
|Cash & Cash Equivalents||438.20M|
|Net Cash Per Share||$6.20|
|Equity / Book Value||420.28M|
|Book Value Per Share||6.14|
In the last 12 months, operating cash flow was -$110.06 million and capital expenditures -$626,000, giving a free cash flow of -$110.69 million.
|Operating Cash Flow||-110.06M|
|Free Cash Flow||-110.69M|
|FCF Per Share||-$1.65|
Dividends & Yields
Kura Oncology does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The average price target for Kura Oncology is $34.17, which is 184.04% higher than the current price. The consensus rating is "Buy".
|Price Target Difference||184.04%|
|Revenue Growth Forecast (5Y)||n/a|
|EPS Growth Forecast (5Y)||n/a|
This stock does not have any record of stock splits.
|Last Split Date||n/a|